We are live on ! Find out more
NARI

Inari Medical, Inc. Common Stock

Delisted

NARI was delisted on the 18th of February, 2025.

231 hedge funds and large institutions have $2.65B invested in Inari Medical, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 89 increasing their positions, 82 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

9% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 82

8% less funds holding

Funds holding: 252231 (-21)

18% less capital invested

Capital invested by funds: $3.24B → $2.65B (-$584M)

34% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 53

51% less call options, than puts

Call options by funds: $4.86M | Put options by funds: $9.88M

Holders
231
Holders Change
-21
Holders Change %
-8.33%
% of All Funds
3.33%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
35
Increased
89
Reduced
82
Closed
53
Calls
$4.86M
Puts
$9.88M
Net Calls
-$5.02M
Net Calls Change
+$17.5M
Name Holding Trade Value Shares
Change
Change in
Stake
CCM
251
Cinctive Capital Management
New York
-$1.05M -16,127 Closed
LCM
252
Legato Capital Management
California
-$1M -15,479 Closed
SOMRS
253
State of Michigan Retirement System
Michigan
-$799K -12,300 Closed
DTL
254
Dynamic Technology Lab
Singapore
-$744K -11,462 Closed
Federated Hermes
255
Federated Hermes
Pennsylvania
-$743K -11,447 Closed
NMIMC
256
Northwestern Mutual Investment Management Company
Wisconsin
-$739K -11,387 Closed
N
257
Natixis
France
-$621K -9,559 Closed
D.E. Shaw & Co
258
D.E. Shaw & Co
New York
-$506K -7,800 Closed
YIH
259
Y-Intercept (HK)
Hong Kong
-$504K -7,762 Closed
X
260
Xponance
Pennsylvania
-$489K -7,531 Closed
MML Investors Services
261
MML Investors Services
Massachusetts
-$387K -5,955 Closed
PTC
262
Petrus Trust Company
Texas
-$386K -5,944 Closed
JAM
263
Jupiter Asset Management
United Kingdom
-$353K -5,442 Closed
VPIM
264
Vanguard Personalized Indexing Management
California
-$313K -4,821 Closed
OR
265
Olympiad Research
Connecticut
-$297K -4,577 Closed
SAM
266
Securian Asset Management
Minnesota
-$274K -4,223 Closed
CC
267
Corton Capital
Ontario, Canada
-$239K -3,686 Closed
CGH
268
Crossmark Global Holdings
Texas
-$237K -3,645 Closed
VA
269
Vident Advisory
Georgia
-$223K -3,428 Closed
CCIA
270
Campbell & Co Investment Adviser
Maryland
-$215K -3,308 Closed
AWS
271
Atria Wealth Solutions
New York
-$211K -3,256 Closed
William Blair & Company
272
William Blair & Company
Illinois
-$203K -3,130 Closed
SSG
273
Summit Securities Group
New York
-$198K -3,057 Closed
VIA
274
Virtus Investment Advisers
Connecticut
-$160K -2,467 Closed
PHK
275
Point72 Hong Kong
Hong Kong
-$117K -1,800 Closed

NARI Hedge Fund Activity: Q1 2024 in Review

231 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q1 2024, worth a combined $2.65B — down 18% from $3.24B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of NARI and 35 opened new positions — a net loss of 18 holders — while 82 trimmed existing stakes and 89 added.

The largest buyer was BlackRock, adding an estimated $95.4M. The largest seller was Wellington Management Group, cutting an estimated $177M.

  • 231 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q1 2024, down from 252 in Q4 2023.
  • Funds reported $2.65B of Inari Medical, Inc. Common Stock stock for Q1 2024, down 18% quarter-over-quarter.
  • 35 funds opened new Inari Medical, Inc. Common Stock positions in Q1 2024 and 53 closed out, a net change of -18 holders.
  • The largest Inari Medical, Inc. Common Stock buyer in Q1 2024 was BlackRock, an estimated $95.4M added.
  • The largest Inari Medical, Inc. Common Stock seller in Q1 2024 was Wellington Management Group, an estimated $177M sold.

Based on aggregated 13F filings for Q1 2024.